Capital One Financial Corp (COF) Falls 2.57% for December 21

Equities Staff  |

One of the S&P 500’s big losers for Monday December 21 was Capital One Financial Corp (COF). The company’s stock fell 2.57% to $72.47 on volume of 5.1 million shares.

The stock opened the day at 73.92 and traded between a low of $72.32 and a high of $73.92. The stock finished the day down $1.91 per share. Capital One Financial Corp has an average daily volume of 2.87 million and a total float of 532.05 million shares. The 50-day SMA for Capital One Financial Corp is $77.27 and its 200-day SMA is $79.90. The high for the stock over the last 52 weeks is $92.10 and the low is $67.73.

Capital One Financial Corp is a financial services holding company. The Company with its banking and non-banking subsidiaries markets financial products and services.

Capital One Financial Corp is centered in McLean, VA, and has 46,900 employees. Today’s trading day leaves the company with a market cap of $38.56 billionwith a P/E Ratio of 10.1. The company has a P/S ratio of 1.61, P/B ratio of 0.81, and a 4.2.

For a complete fundamental analysis analysis of Capital One Financial Corp, check out’s Stock Valuation Analysis report for COF. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

DirectView Holdings Inc

DirectView Holdings Inc designs and installs surveillance systems, digital video recording and services. The company through its subsidiaries operates within two divisions security and surveillance and video conferencing services.